Morley Timothy J, Mikulski Matthew F, Rade Matthew, Chalhoub Jean, Desilets David J, Romanelli John R
Surgery, UMass Chan Medical School - Baystate, Springfield, MA, USA.
Baystate Medical Center, 759 Chestnut Street, Springfield, MA, 01199, USA.
Surg Endosc. 2023 Feb;37(2):1013-1020. doi: 10.1007/s00464-022-09596-x. Epub 2022 Sep 12.
Achalasia is a rare disorder of esophageal motility that induces progressive intolerance to oral intake. Other esophageal dysmotility disorders include esophagogastric junction outflow obstruction (EGJOO), distal esophageal spasm (DES), hypercontractile esophagus (HE), and other minor disorders of peristalsis (MDP) and can present similarly to achalasia despite different pathophysiologies. Prior studies have demonstrated the safety and efficacy of POEM in the treatment of achalasia, but little is reported regarding POEM's role in treating non-achalasia esophageal dysmotility disorders (NAEDD). This study aims to assess the safety and efficacy of POEM in the treatment of NAEDD.
This is a retrospective review of consecutive POEM cases from June 1, 2011, to February 1, 2021. NAEDD were characterized according to the Chicago classification. Primary outcome measure was the resolution of preoperative symptoms. Secondary outcomes include preoperative diagnosis, myotomy length, conversion to laparoscopic or open procedure, operative time, and length of stay (LOS). Technical success was defined as the completion of an 8 cm myotomy including the esophagogastric junction (EGJ) and extending 2 cm distal to the EGJ. Clinical success was defined as a postoperative Eckardt score ≤ 3.
Of 124 cases of POEM performed during the study period, 17 were performed for NAEDD. Technical success was achieved in all 17 patients (100%). Of the fifteen patients that had documented postoperative Eckardt scores, 13 were ≤ 3, achieving a clinical success rate of 87%. Subgroup analysis (HE/MDP/DES vs. EGJOO) showed no significant differences in the preoperative or postoperative Eckardt scores between groups, and both groups demonstrated a significant decrease in Eckardt scores after POEM. No cases were aborted for technical or clinical reasons, and there were no adverse outcomes.
POEM is a safe and efficacious treatment modality for NAEDD. Further work is needed to develop optimal treatment strategies for this complex group of diseases.
贲门失弛缓症是一种罕见的食管动力障碍性疾病,会导致患者对经口摄入食物的耐受性逐渐下降。其他食管动力障碍性疾病包括食管胃交界部流出道梗阻(EGJOO)、食管远端痉挛(DES)、高收缩性食管(HE)以及其他轻微蠕动障碍(MDP),尽管它们的病理生理学不同,但临床表现可能与贲门失弛缓症相似。既往研究已证实经口内镜下肌切开术(POEM)治疗贲门失弛缓症的安全性和有效性,但关于POEM在治疗非贲门失弛缓症食管动力障碍性疾病(NAEDD)中的作用报道较少。本研究旨在评估POEM治疗NAEDD的安全性和有效性。
这是一项对2011年6月1日至2021年2月1日期间连续进行的POEM病例的回顾性研究。NAEDD根据芝加哥分类进行特征描述。主要结局指标是术前症状的缓解情况。次要结局包括术前诊断、肌切开长度、转为腹腔镜或开放手术、手术时间和住院时间(LOS)。技术成功定义为完成一段8厘米的肌切开术,包括食管胃交界部(EGJ)并向EGJ远端延伸2厘米。临床成功定义为术后埃卡德特评分≤3分。
在研究期间进行的124例POEM手术中,17例是针对NAEDD进行的。所有17例患者(100%)均取得技术成功。在有术后埃卡德特评分记录的15例患者中,13例≤3分,临床成功率为87%。亚组分析(HE/MDP/DES与EGJOO)显示,两组术前或术后埃卡德特评分无显著差异,且两组在POEM术后埃卡德特评分均显著降低。没有病例因技术或临床原因中止手术,也没有不良结局。
POEM是治疗NAEDD的一种安全有效的治疗方式。对于这一复杂疾病群体,需要进一步开展工作以制定最佳治疗策略。